Agilent Technologies, Inc. (NYSE:A) Shares Sold by CANADA LIFE ASSURANCE Co

CANADA LIFE ASSURANCE Co decreased its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 1.0% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 316,723 shares of the medical research company’s stock after selling 3,049 shares during the quarter. CANADA LIFE ASSURANCE Co owned about 0.11% of Agilent Technologies worth $46,104,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Livelsberger Financial Advisory purchased a new stake in shares of Agilent Technologies in the 4th quarter valued at $26,000. MV Capital Management Inc. lifted its position in shares of Agilent Technologies by 120.7% during the 4th quarter. MV Capital Management Inc. now owns 192 shares of the medical research company’s stock worth $27,000 after purchasing an additional 105 shares during the last quarter. VisionPoint Advisory Group LLC purchased a new stake in Agilent Technologies in the fourth quarter valued at $29,000. Rise Advisors LLC lifted its position in Agilent Technologies by 527.8% in the first quarter. Rise Advisors LLC now owns 226 shares of the medical research company’s stock valued at $33,000 after acquiring an additional 190 shares during the last quarter. Finally, YHB Investment Advisors Inc. purchased a new stake in shares of Agilent Technologies in the first quarter valued at about $34,000.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on the stock. Evercore ISI boosted their price target on shares of Agilent Technologies from $126.00 to $130.00 and gave the stock an “in-line” rating in a research note on Tuesday, July 2nd. Robert W. Baird reduced their price target on shares of Agilent Technologies from $147.00 to $136.00 and set an “outperform” rating on the stock in a report on Thursday, May 30th. Wolfe Research downgraded shares of Agilent Technologies from an “outperform” rating to a “peer perform” rating in a report on Thursday, June 27th. UBS Group reduced their price target on shares of Agilent Technologies from $155.00 to $141.00 and set a “neutral” rating on the stock in a report on Thursday, May 30th. Finally, Bank of America upped their price target on shares of Agilent Technologies from $134.00 to $140.00 and gave the company a “neutral” rating in a report on Tuesday, June 25th. One research analyst has rated the stock with a sell rating, six have given a hold rating and ten have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $138.06.

Agilent Technologies Stock Up 2.2 %

Agilent Technologies stock traded up $2.91 during trading hours on Thursday, hitting $137.07. The company had a trading volume of 654,169 shares, compared to its average volume of 1,771,503. The firm has a market capitalization of $39.99 billion, a P/E ratio of 31.73, a price-to-earnings-growth ratio of 4.44 and a beta of 1.05. The company has a debt-to-equity ratio of 0.34, a current ratio of 2.15 and a quick ratio of 1.64. The firm’s fifty day moving average is $135.29 and its 200-day moving average is $137.53. Agilent Technologies, Inc. has a fifty-two week low of $96.80 and a fifty-two week high of $155.35.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, May 29th. The medical research company reported $1.22 earnings per share for the quarter, beating the consensus estimate of $1.19 by $0.03. The firm had revenue of $1.57 billion for the quarter, compared to analyst estimates of $1.58 billion. Agilent Technologies had a net margin of 18.84% and a return on equity of 26.25%. The company’s revenue for the quarter was down 8.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.27 EPS. On average, research analysts forecast that Agilent Technologies, Inc. will post 5.24 earnings per share for the current year.

Agilent Technologies Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, July 24th. Investors of record on Tuesday, July 2nd were paid a dividend of $0.236 per share. This represents a $0.94 annualized dividend and a yield of 0.69%. The ex-dividend date of this dividend was Tuesday, July 2nd. Agilent Technologies’s payout ratio is currently 22.22%.

Insider Activity at Agilent Technologies

In other news, SVP Dominique Grau sold 15,000 shares of the stock in a transaction on Monday, June 10th. The shares were sold at an average price of $133.28, for a total value of $1,999,200.00. Following the completion of the transaction, the senior vice president now owns 49,486 shares in the company, valued at approximately $6,595,494.08. The sale was disclosed in a filing with the SEC, which is available at this link. In other news, CEO Padraig Mcdonnell sold 1,958 shares of the firm’s stock in a transaction dated Monday, June 3rd. The shares were sold at an average price of $130.00, for a total value of $254,540.00. Following the transaction, the chief executive officer now owns 25,185 shares of the company’s stock, valued at approximately $3,274,050. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Dominique Grau sold 15,000 shares of the firm’s stock in a transaction dated Monday, June 10th. The shares were sold at an average price of $133.28, for a total transaction of $1,999,200.00. Following the completion of the transaction, the senior vice president now directly owns 49,486 shares in the company, valued at approximately $6,595,494.08. The disclosure for this sale can be found here.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.